147 related articles for article (PubMed ID: 37956658)
1. Pulmonary injury after radioactive iodine therapy in pediatric papillary thyroid cancer: a case report.
Halada S; Leftin Dobkin S; Baran JA; Sisko L; Robbins SL; Rapp JB; Young LR; Bauer AJ
Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 37956658
[TBL] [Abstract][Full Text] [Related]
2. Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer.
Sun Y; Sun Q; Tian J; He X
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1413-e1423. PubMed ID: 37167097
[TBL] [Abstract][Full Text] [Related]
3. Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report.
Toda S; Yamamoto Y; Ookubo Y; Hayashi H; Tsunematsu T; Kadoya M; Masudo K; Iwasaki H
Gland Surg; 2023 Oct; 12(10):1441-1448. PubMed ID: 38021198
[TBL] [Abstract][Full Text] [Related]
4. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Mahajan P; Dawrant J; Kheradpour A; Quintanilla NM; Lopez ME; Orth RC; Athanassaki I; Venkatramani R
Thyroid; 2018 Nov; 28(11):1450-1454. PubMed ID: 30226445
[TBL] [Abstract][Full Text] [Related]
5. Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Iyer P; Mayer JL; Ewig JM
Thyroid; 2014 Jan; 24(1):169-74. PubMed ID: 23544852
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma of the lung and pulmonary metastasis of papillary thyroid carcinoma: a case report.
Aminorroaya A; Khoshniatnikoo M; Farrokhpour H; Vafaeimanesh J; Bagherzadeh M
J Med Case Rep; 2019 Aug; 13(1):259. PubMed ID: 31422769
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
Higuchi Y; Motoki T; Ishida H; Kanamitsu K; Washio K; Oyama T; Noda T; Tsurumaru Y; Okada A; Tsukahara H; Shimada A
BMC Cancer; 2017 Nov; 17(1):775. PubMed ID: 29162036
[TBL] [Abstract][Full Text] [Related]
8. Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.
Jang EK; Kim WG; Kim HC; Huh JW; Kwon H; Choi YM; Jeon MJ; Kim TY; Shong YK; Ryu JS; Kim WB
PLoS One; 2015; 10(4):e0125114. PubMed ID: 25923702
[TBL] [Abstract][Full Text] [Related]
9. Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases.
Yang J; Zheng R; Liang M; Jia Y; Lin L; Geng J; Chen S; Li YX
Front Oncol; 2019; 9():558. PubMed ID: 31316914
[No Abstract] [Full Text] [Related]
10. Thyroid volume is the key predictor of hyperthyroidism remission after radioactive iodine therapy in pediatric patients.
Sheremeta M; Korchagina M; Trukhin A; Nagaeva E; Bezlepkina O; Peterkova V
Eur J Pediatr; 2023 Nov; 182(11):4931-4937. PubMed ID: 37606704
[TBL] [Abstract][Full Text] [Related]
11. Case report: identification of
Ma J; Wang B; Meng E; Meng X
Gland Surg; 2021 Sep; 10(9):2874-2879. PubMed ID: 34733735
[TBL] [Abstract][Full Text] [Related]
12. Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma.
Suydam AC; Bach A; Markovina S; Grigsby P; Sprague J; Armstrong AE
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e984-e987. PubMed ID: 37565829
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.
Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
[TBL] [Abstract][Full Text] [Related]
15. Focal bronchiectasis causing abnormal pulmonary radioiodine uptake in a patient with well-differentiated papillary thyroid carcinoma.
Gargya A; Chua E
Case Rep Endocrinol; 2012; 2012():452758. PubMed ID: 23097725
[TBL] [Abstract][Full Text] [Related]
16. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW
Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993
[TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy.
Myint ZW; Chow RD
J Community Hosp Intern Med Perspect; 2015; 5(1):26360. PubMed ID: 25656675
[TBL] [Abstract][Full Text] [Related]
18. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma.
Maciel J; Cavaco D; Silvestre C; Simões Pereira J; Vilar H; Leite V
Clin Endocrinol (Oxf); 2022 Dec; 97(6):814-821. PubMed ID: 35192239
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of seven cases of pulmonary malignant tumors in children].
Xu D; Chen ZM; Gu WZ; Wang YS; Huang MX; Tang LF; Zhang YY; Jiang Y
Zhonghua Er Ke Za Zhi; 2017 Apr; 55(4):298-303. PubMed ID: 28441828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
